Real-time enrollment status for this fibrodysplasia ossificans progressiva clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:33 AM UTC
| NCT Number | NCT06508021 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Fibrodysplasia Ossificans Progressiva |
| Phase | Clinical Trial |
| Target Enrollment | 92 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Ashibio Inc |
| Last Updated on CT.gov | October 14, 2025 (Oct 14, 2025) |
As of March 2, 2026: Clinical trial NCT06508021 is currently active_not_recruiting participants. This clinical trial study for fibrodysplasia ossificans progressiva is not currently accepting new participants at 3 locations across the United States. The study is sponsored by Ashibio Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06508021 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06508021 was last updated Oct 14, 2025 (October 14, 2025). HelloStudys verifies this status automatically.